Sevoflurane
Mastectomy
Gangnam Severance HospitalSmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 81/ 100
Competitive context
12 Active assets in the Mastectomy cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
DICLOFENAC Nanjing Medical University | Phase 4 | BB |
Naproxen Nanjing Medical University | Phase 4 | BB |
Oxycodone Nanjing Medical University | Phase 4 | B |
Dfn-15 Nanjing Medical University | Phase 4 | B |
MIDAZOLAM University of Alabama at Birmingham | Early Phase 1 | CC |
View all 17 →
Same molecule, other indications
Sevoflurane is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →